Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Frontiers in Immunology|March 7, 2014
The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ TransplantationVeena Roberts, John Stagg, Karen M DwyerJournal of Nephrology|April 16, 2026
Immunoglobulin A nephropathy-novel insights in long-term outcomes and pathophysiology leading to international guideline modification and new emerging therapiesMartin Klein, Veena Roberts, Muhammad M JavaidThrombosis Journal|November 16, 2021
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19David Oliver Hamilton, Alexander Main-Ian, Jessie Tebbutt, et al.Purinergic Signalling|August 28, 2016
CD39 overexpression does not attenuate renal fibrosis in the unilateral ureteric obstructive model of chronic kidney diseaseVeena Roberts, B Lu, J Chia, et al.Purinergic Signalling|November 29, 2012
The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injuryVeena Roberts, Bo Lu, Siddharth Rajakumar, et al.Oxford Medical Case Reports|June 20, 2019
Eculizumab therapy in gemcitabine-induced thrombotic microangiopathy in a renal transplant recipientKylie Martin, Veena Roberts, Geoff Chong, et al.Oxford Medical Case Reports|February 26, 2019
Paraneoplastic systemic lupus erythematosus associated with colorectal cancerMatthew J Rees, Adam Steinberg, Evange Romas, et al.Transplantation|February 16, 2017
The Differential Effect of Apyrase Treatment and hCD39 Overexpression on Chronic Renal Fibrosis After Ischemia-Reperfusion InjuryVeena Roberts, Duncan J Campbell, Bo Lu, et al.Bioorganic & Medicinal Chemistry Letters|December 2, 2017
AMP and adenosine are both ligands for adenosine 2B receptor signalingJessica K Holien, Benjamin Seibt, Veena Roberts, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 14, 2017
Overexpression of Human CD55 and CD59 or Treatment with Human CD55 Protects against Renal Ischemia-Reperfusion Injury in MiceAnjan K Bongoni, Bo Lu, Evelyn J Salvaris, et al.Pageof 2